Eric Popp works with technology and healthcare startups from formation to exit, advising founders and boards on governance matters, venture deals, strategic transactions and IPOs. He also represents venture capital firms in connection with investments, portfolio company exits, and other strategic initiatives.

Download full bio 


  • Evisort Closes $35 Million Series B 

  • Milestone Pharmaceuticals – $95 Million IPO 

  • Billtrust to Combine With South Mountain, a Special Purpose Acquisition Company, at $1.3 Billion Value 

  • Thriveworks Closes Series B Financing 

  • General Catalyst Leads Eleanor Health’s $50 Million Series C  

  • View all


  • Boston College Law School
    JD, cum laude, 2018

  • University of Massachusetts, Amherst
    BA, Economics

Admissions & Credentials